Kuribayashi, T., Kinoshita, R., Ninomiya, K., Makimoto, G., Kubo, T., Rai, K., Ichihara, E., Hotta, K., Tabata, M., Maeda, Y., Kiura, K., Toyooka, S., Sakaguchi, M., Ohashi, K. (2025). Plasma S100A8/A9 level predicts response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer. Scientific Reports. https://doi.org/10.1038/s41598-025-87232-z